Furthermore, the stemness of glioma cells was enhanced by TGF‐β treatment in a concentration‐dependent manner, characterized as the promotion of spheroid formation (Fig. 1D) and upregulation of ALDH1 activity (Fig. 1E). The gene discussed is ALDH1A1; the disease is central nervous system cancer.